论文部分内容阅读
目的探讨阿奇霉素联合孟鲁司特治疗小儿支原体肺炎的疗效。方法将82例肺炎支原体肺炎患儿,随机分为两组,对照组41例予阿奇霉素序贯疗法5～7d静脉治疗;观察组41例在对照组治疗的基础上,加用孟鲁司特钠片。结果观察组总有效率92.7%明显大于对照组的70.7%,(P<0.05)。结论阿奇霉素联合孟鲁司特治疗小儿肺炎支原体肺炎,能明显减轻患儿咳嗽症状,减少住院时间和诱发哮喘的概率,不良反应较少,用药安全,疗效确切,值得在临床上推广应用。
Objective To investigate the curative effect of azithromycin combined with montelukast on children with mycoplasma pneumonia. Methods 82 cases of children with Mycoplasma pneumoniae pneumonia were randomly divided into two groups, the control group 41 cases of azithromycin sequential therapy 5 ~ 7d intravenous treatment; observation group 41 cases in the control group based on the treatment, plus montelukast sodium sheet. Results The total effective rate in observation group was 92.7%, which was significantly higher than that in control group (70.7%, P <0.05). Conclusion Azithromycin combined with montelukast treatment of children with Mycoplasma pneumoniae pneumonia can significantly reduce the symptoms of children with cough, reduce the length of hospital stay and the risk of asthma, less adverse reactions, medication safety, curative effect is worthy of clinical application.